They aim to ensure security of supply for antibiotics
For high-risk patients
Final review of Merck's pill to be made in February
Booster dose is needed to extend vaccine protection against Omicron
Fifth vaccine Novavax to be available next year
Mix-and-match offers better immune response
European medicines watchdog starts rolling review of Valneva's shot
EMA recommends approval of Comirnaty for children aged 5 to 11
Not for everyone, though
To ensure increased vaccine supply in the EU
Anti-inflammatory RoActemra in the spotlight
Skin rash, two kidney disorders being studied by EMA
Ryeqq granted marketing authorisation
Decision not expected before September
Final call on authorisation can be expected in two months
Oral contraceptive to be marketed in Europe
Developed by Sinovac
Smaller set of additional data to the European Medicines Agency will do
Set to begin Sputnik factory visits in Russia
Russian vaccine maker takes offense